Last updated: December 21, 2023
Sponsor: University Hospital, Rouen
Overall Status: Active - Recruiting
Phase
N/A
Condition
Asthma
Treatment
Blood sample
Nasopharyngeal swab
Expectoration
Clinical Study ID
NCT06044051
2023/0091/OB
Ages < 24 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Infants less than 24 months old
- Follow-up by a pneumo-pediatrician for severe asthma in infants
- Requiring etiological investigations and assessment of severity in dayhospitalization, including bronchial fibroscopy (HAS 2009)
- Parent informed of the research and having signed consent
Exclusion
Exclusion Criteria:
- Prematurity <32 WA
- Congenital heart disease with significant left to right shunt
- Chronic respiratory disease other than infant asthma (cystic fibrosis, bronchiolitisobliterans)
- Antibiotic therapy in progress or administered the seven days preceding the date ofinclusion (day hospitalization)
- Refusal of bronchial fibroscopy
Study Design
Total Participants: 100
Treatment Group(s): 3
Primary Treatment: Blood sample
Phase:
Study Start date:
September 26, 2023
Estimated Completion Date:
September 26, 2026
Connect with a study center
Rouen University Hospital
Rouen,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.